The most importantly, this is the first report to demonstrate that alterations in glucose metabolism are revealed in tamoxifen-resistant breast cancer cells and that the HIF-1α pathway and Akt/mTOR oncogenic signaling molecules are associated with the Warburg effect in these cells. The gene discussed is AKT1; the disease is breast cancer.